Clinical Trials Browser

Active not recruiting × Leukemia × Injections × Clear all

NCT04874480 2026-01-09

Tegavivint for the Treatment of Relapsed or Refractory Leukemia

Phase 1 Active not recruiting

Other hematologic neoplasm

Leukemia